Characterization of ischemic etiology in heart failure with reduced ejection fraction randomized clinical trials: A

Marco Canepa1, Gianluca Anastasia2, Pietro Ameri1

  • 1Cardiovascular Unit, Department of Internal Medicine, University of Genova, Italy; Cardiovascular Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

PubMed

Insights

Most heart failure with reduced ejection fraction (HFrEF) randomized controlled trials (RCTs) lack clear definitions for ischemic etiology. Assignment often relies on clinical judgment, with prior myocardial infarction (MI) being a key factor, though its reporting has declined.

Area of Science:

  • Cardiology
  • Clinical Trials
  • Heart Failure Research

Background:

  • Heart failure with reduced ejection fraction (HFrEF) is a significant cardiovascular condition.
  • Accurate etiological classification, particularly ischemic versus non-ischemic, is crucial for guiding treatment.
  • Randomized controlled trials (RCTs) are vital for advancing HFrEF therapies.

Purpose of the Study:

  • To systematically review and analyze the methods used to assign ischemic etiology in HFrEF RCTs.
  • To assess the prevalence and definitions of ischemic heart disease components within these trials.
  • To identify trends in the reporting of ischemic etiology over time.

Main Methods:

  • Systematic review and meta-analysis of 145 HFrEF RCTs.
  • Extraction and analysis of data on definitions, rates of ischemic etiology, and specific components (coronary artery disease, myocardial infarction, revascularization, angina).
  • Correlation analysis to determine the strength of association between components and assigned ischemic etiology.

Main Results:

  • A majority of HFrEF RCTs (84.2%) lacked clear definitions for ischemic etiology.
  • Ischemic etiology was assigned in 57.8% of patients across 122 RCTs.
  • Prior myocardial infarction (MI) showed the strongest correlation with assigned ischemic etiology, but its reported rate decreased over time, while prior revascularization increased.

Conclusions:

  • There is a significant lack of standardized definitions for ischemic etiology in HFrEF RCTs.
  • Investigator clinical judgment frequently dictates the assignment of ischemic etiology.
  • The declining rate of reported prior MI warrants attention, alongside the increasing rate of prior revascularization, in future trial design and analysis.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
374
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
311
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K